For the quarter ending 2025-12-27, HAE made $338,967K in revenue. $44,740K in net income. Net profit margin of 13.20%.
| Income Statement | 2025-12-27 | 2025-09-27 | 2025-06-28 | 2025-03-29 |
|---|---|---|---|---|
| Net revenues | 338,967 | 327,315 | 321,394 | 330,599 |
| Cost of goods sold | 136,581 | 132,571 | 129,150 | 137,549 |
| Gross profit | 202,386 | 194,744 | 192,244 | 193,050 |
| Research and development | 14,187 | 14,872 | 16,261 | 15,914 |
| Impairment of intangible assets | - | - | - | 598* |
| Remeasurement of contingent consideration | - | - | - | -21,229* |
| Selling, general and administrative | 109,154 | 101,615 | 110,719 | 115,136 |
| Amortization of acquired assets | 10,933 | 11,182 | 11,392 | 11,296 |
| Impairment of intangible assets | 716 | 8,584 | - | - |
| Total operating expenses | 134,990 | 136,253 | 138,372 | 121,715 |
| Operating income | 67,396 | 58,491 | 53,872 | 71,335 |
| Interest and other expense, net | -7,421 | -7,206 | -8,703 | -598 |
| Income before provision for income taxes | 59,975 | 51,285 | 45,169 | 70,737 |
| Provision for income taxes | 15,235 | 12,601 | 11,138 | 12,779 |
| Net income | 44,740 | 38,684 | 34,031 | 57,981 |
| Basic EPS | 0.96 | 0.81 | 0.71 | 1.179 |
| Diluted EPS | 0.95 | 0.81 | 0.7 | 1.172 |
| Basic Average Shares | 46,792,000 | 47,590,000 | 48,111,000 | 49,193,000 |
| Diluted Average Shares | 46,987,000 | 47,664,000 | 48,353,000 | 49,477,000 |
HAEMONETICS CORP (HAE)
HAEMONETICS CORP (HAE)